Looking for an experienced partner who can develop innovative, advanced and practical diagnostic immunoassays with an excellent performance and impressive sensivity? Contact us.
apDia aims to offer innovative, advanced and practical diagnostic immunoassays that stand out by their
Since the availability of highly specific biomarkers is of utmost importance in achieving improved diagnostic assays, apDia is also exploring the possibilities to identify novel markers for specific diseases.
Well-characterised, good quality and standardized basic reagents are another prerequisite for the reliable performance of an immunoassay. Therefore, apDia is committed to designing, developing and producing its own biological raw materials as much as possible.
Development of rapid diagnostic assays
Improving the test characteristics of diagnostic assays
Identification and selection of specific biomarkers
Cell culture
Design and development of recombinant antigens
Purification of proteins
apDia has participated or is participating in a number of research projects funded by the EU:
Early diagnosis, treatment and prevention of mood disorders targeting the activated inflammatory response system (EU 2008-2013)
European Multicentre Tics in Children Studies (EU 2011-2017)
Advanced Immuno-neuro-endocrine Diagnostics in Psychiatric Disorders (EU IAPP 2012-2016)
Brain Imaging Return to Health (EU ITN 2013-2017)
About research on imbalances in the immune system as a cause for mood disorders
Etiam magna arcu, ullamcorper ut pulvinar et, ornare sit amet ligula. Aliquam vitae bibendum lorem. Cras id dui lectus. Pellentesque nec felis tristique urna lacinia sollicitudin ac ac ex. Maecenas mattis faucibus condimentum. Curabitur imperdiet felis at est posuere bibendum. Sed quis nulla tellus.
63739 street lorem ipsum City, Country
+12 (0) 345 678 9
info@company.com